Bharwani Annika, Li Dan, Vermund Sten H
Public Health, Yale University, New Haven, USA.
Cureus. 2023 Jun 11;15(6):e40268. doi: 10.7759/cureus.40268. eCollection 2023 Jun.
COVID-19 lockdowns have led to significant disruptions in preventative health services worldwide. This review aims to assess the impact of COVID-19 lockdowns on worldwide preventive cancer screening participation. Major medical databases were searched using the keywords 'lockdown,' 'cancer,' and 'screening or diagnosis,' and relevant articles were evaluated against inclusion and exclusion criteria.The final review consisted of 38 studies. The impact of COVID-19 on screening uptake was categorized based on cancer type. All types of screening had decreased participation during or around the lockdown period. Racial and socioeconomic disparities, provider-related barriers, and patient attitudes about service disruptions during the pandemic were also highlighted in this review. Future research should focus on data from low- and middle-income countries to obtain a more comprehensive picture of the problem. Policy interventions that adopt self-screening or different screening intervals can also be considered to reduce impacts in future crises. Insights from existing studies and future research will allow for more proactive measures to manage future disruptions.
新冠疫情封锁措施已导致全球预防性医疗服务受到重大干扰。本综述旨在评估新冠疫情封锁措施对全球预防性癌症筛查参与情况的影响。使用关键词“封锁”“癌症”和“筛查或诊断”检索了主要医学数据库,并根据纳入和排除标准对相关文章进行了评估。最终综述纳入了38项研究。新冠疫情对筛查参与率的影响根据癌症类型进行了分类。在封锁期间或前后,各类筛查的参与率均有所下降。本综述还强调了种族和社会经济差异、与医疗服务提供者相关的障碍以及疫情期间患者对服务中断的态度。未来的研究应侧重于低收入和中等收入国家的数据,以更全面地了解这一问题。也可以考虑采取自我筛查或不同筛查间隔等政策干预措施,以减少未来危机中的影响。现有研究和未来研究的见解将有助于采取更积极的措施来应对未来的干扰。